These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27058583)

  • 21. Esophageal stricture secondary to drug-induced toxic epidermal necrolysis presenting in an adult: an unusual complication of a rare disease.
    Njei B; Schoenfeld A; Vaziri H
    Conn Med; 2013 Oct; 77(9):541-4. PubMed ID: 24273804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD; Schafer PA
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxic epidermal necrolysis associated with acute infection by Mycoplasma pneumoniae].
    Calvano RA; Scacchi MF; Sojo MM; Díaz SM; Volonteri VI; Giachetti AC
    Arch Argent Pediatr; 2013; 111(1):e24-7. PubMed ID: 23381713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence of Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol and piroxicam.
    Xiong H; Liu G; Xiao J; Han Y; Liu T; Wan J; Yang J; Ding J; Dong X
    Eur J Dermatol; 2020 Oct; 30(5):620-621. PubMed ID: 33185537
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Formula: see text]evidence of neuropsychological dysfunction in Stevens-Johnson Syndrome and toxic epidermal necrolysis: case report.
    Henry GK
    Clin Neuropsychol; 2014; 28(5):841-50. PubMed ID: 24942517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T; Uchi H; Moroi Y; Furue M
    Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febuxostat (Adenuric). Toxic epidermal necrolysis and severe hypersensitivity reactions added to the EU SPC.
    Prescrire Int; 2015 Jun; 24(161):153. PubMed ID: 26436167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?
    Mandelcorn R; Shear NH
    J Am Acad Dermatol; 2003 Apr; 48(4):525-9. PubMed ID: 12664014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic epidermal necrolysis--an unusual cause of colonic perforation. Report of a case.
    Carter FM; Mitchell CK
    Dis Colon Rectum; 1993 Aug; 36(8):773-7. PubMed ID: 8348869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.
    Worswick S; Cotliar J
    Dermatol Ther; 2011; 24(2):207-18. PubMed ID: 21410610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing's disease.
    González-Ramos J; Lamas C; Bellón T; Ruiz-Bravo E; RamIrez E; Lerma V; Lecumberri B
    Indian J Dermatol Venereol Leprol; 2020; 86(5):515-518. PubMed ID: 30688217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchial obstruction due to respiratory mucosal sloughing in toxic epidermal necrolysis.
    Dasgupta A; O'Malley J; Mallya R; Williams JG
    Thorax; 1994 Sep; 49(9):935-6. PubMed ID: 7940439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapidly Progressing Severe Cutaneous Adverse Reaction With Acute Kidney Injury After Drug Exposure: An Uncommon Presentation.
    Rodgers BK; Kumar AB
    Am J Ther; 2016; 23(3):e916-9. PubMed ID: 24832386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.